Report Scope & Overview:

The Cancer Registry Software Market Size was valued at USD 75.45 billion in 2022, and is expected to reach USD 171.39 billion by 2030, and grow at a CAGR of 10.8% over the forecast period 2023-2030.

A cancer incidence reporting system is mostly installed and maintained using cancer registry software, a subtype of illness registry. Analysts studying on cancer and its causes might consult the cancer registry system for information. Since cancer is one of the leading causes of mortality, this kind of registry is essential for precisely identifying trends and, ultimately, for enhancing care for cancer patients. Data on cancer cases, from diagnostic testing to survival rates, should be collected. A cancer registry is a computerized platform that enables software solutions to organize, collect, and store data on cancer patients in order to evaluate the conditions, outcomes, and exposure to drugs and medical devices that are specific to a given malignancy.

Cancer Registry Software Market Revenue Analysis

To get more information on Cancer Registry Software Market - Request Sample Report

A technology that aids in the collection, upkeep, and provision of cancer-specific data that aids in the establishment of cancer registries is cancer patient registry software. Registries are crucial for cancer surveillance because they enable acceptance of medical professionals' and researchers' efforts as well as the effectiveness of traditional cancer treatments. The foundation for cancer research as well as the evaluation and analysis of cancer preventive and control activities are provided by surveillance data.



  • Increasing Cancer Prevalence and Favorable Government Initiatives

  • Increasing Demand for Better Care and Lower Healthcare Costs

  • Growing Acceptance of Ehrs

  • Cancer Patient Registry Data Are Being Used Increasingly for Post-Marketing Monitoring


  • Security of Personal Information and Privacy Issues


  • Expansion in the Number of Accountable Care Organizations

  • The Development of Cancer Patient Registries in the Cloud


  • Inability to integrate and communicate

  • Lack of Willingness to Adopt Modern Solutions

  • Insufficient Knowledge


Nearly every business has been impacted by the unmatched worldwide public health emergency known as COVID-19, and the long-term impacts are expected to have an influence on industry growth throughout the course of the forecast period. To ensure the inclusion of underlying COVID-19 problems and potential future directions, our continuous research expands upon our research approach. The paper provides information on COVID-19 taking into account changes in consumer demand and behaviour, buying habits, supply chain rerouting, dynamics of contemporary market forces, and significant government initiatives. Taking into account the market impact of COVID-19, the updated report offers insights, analyses, projections, and forecasts.

Impact of Russia Ukraine Conflict

We constantly track and revise reporting on the political and economic unrest brought on by Russia's invasion of Ukraine. The world as a whole is expected to see negative effects, particularly in Eastern Europe, the European Union, Eastern and Central Asia, and the United States. This claim had a significant negative impact on people's lives and livelihoods and has caused significant disruptions to trade dynamics. The international economy is predicted to suffer as a result of the prolonged conflict and unrest in Eastern Europe, with Russia likely to suffer the most severely over the long run.

This study examines how supply and demand affect prices, vendor strategy uptake, and market recommendations for patient registry software in light of the most recent conflict developments and their global responses.

By Type

The desire to streamline and optimize workflows, lessen physician workloads, and the industry's changing landscape are the key factors driving the rise in the use of integrated software in the healthcare sector. Additionally, the government's increased emphasis on population health management, coordinated care, and lowering healthcare costs are encouraging market growth.

By Deployment Model

On-premise and cloud-based approaches have been separated out into separate market segments.

By Database

Public databases and commercial databases are the market's two main divisions. Due to its greater data privacy than a public database, the commercial database has the global cancer registry market's fastest expanding category. The commercial database conforms with the majority of governmental coding requirements. Additionally organized and simple to read is the data. Commercial platforms make it easier for government research institutions to share data, such as the CDC and central cancer registries.

By Functionality

The market is divided into four categories: product outcome assessment, patient care management, cancer reporting to comply with state and federal regulations, and medical research and clinical studies. A program called patient care management offers a wide range of health services to help people keep track of their health, from short-term case management and chronic illness care management to basic care services like making appointments. The goal of product result evaluation is to rate the value of goods and explain the user experience as a benchmark for future design. In several areas of product evaluation, methods and procedures for evaluating user experience are being used.

By End-User

The major purpose of cancer patient registration software in research facilities is to keep track of patients who qualify for clinical trials. Mostly for product development, researchers use the registry's data. For the purpose of maintaining a patient database of people with different types of cancer, many research organisations have constructed their records. Additionally, several research institutions help the creation of cancer patient registries in collaboration with hospitals and organisations.


By Type

  • Standalone Software

  • Integrated Software

By Deployment Model

  • On-premise

  • Cloud-based

By Database

  • Commercial Databases

  • Public Databases

By Functionality

  • Cancer Reporting to Meet State & Federal Regulations

  • Medical Research and Clinical Studies

  • Patient Care Management

  • Product Outcome Evaluation

By End-User

  • Government Organizations & Third-party Administrators (TPAS)

  • Pharmaceutical, Biotechnology, & Medical Device Companies

  • Hospitals & Medical Practices

  • Private Payers

  • Research Centers

Cancer Registry Software Market Segmentation Analysis

Need any customization research on Cancer Registry Software Market - Enquiry Now


The European and North American markets are divided into cancer patient registration software. Over a period of time, North America will continue to hold a large portion of the cancer registration market, starting from its top counter in 2018. players in the software for cancer registration software development, high investment in IT healthcare, and the high level of acceptance of these solutions in the region are all factors that have influenced North America to hold a large share of the cancer registration software market.


Some of the major key players of Cancer Registry Software Market are as follow: Elekta AB (PUB), IBM, Electronic Registry Systems, Inc., McKesson Corporation, Onco, Inc., CONDUENT, INC, ORDINAL DATA, INC, Rocky Mountain Cancer Data Systems, C/Net Solutions and Other Players


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Cancer Registry Software Market Report Scope:
Report Attributes Details
Market Size in 2022 US$ 75.45 Billion
Market Size by 2030 US$ 171.39 Billion
CAGR CAGR of 10.8% From 2023 to 2030
Base Year 2022
Forecast Period 2023-2030
Historical Data 2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Type (Standalone Software, Integrated Software)
• By Deployment Model (On-premise, Cloud-based)
• By Database (Commercial Databases, Public Databases)
• By Functionality (Cancer Reporting to Meet State & Federal Regulations, Medical Research and Clinical Studies, Patient Care Management, Product Outcome Evaluation)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Elekta AB (PUB), IBM, Electronic Registry Systems, Inc., McKesson Corporation, Onco, Inc., MCKESSON CORPORATION, CONDUENT, INC, ORDINAL DATA, INC, Rocky Mountain Cancer Data Systems, C/Net Solutions.
DRIVERS • Increasing Cancer Prevalence and Favorable Government Initiatives
• Increasing Demand for Better Care and Lower Healthcare Costs
• Growing Acceptance of Ehrs
RESTRAINTS • Security of Personal Information and Privacy Issues

Frequently Asked Questions

Ans: The Cancer Registry Software Market size was valued at US$ 75.45 Bn in 2022.

Ans: The Cancer Registry Software Market is to grow at a CAGR of 10.8% over the forecast period 2023-2030.

We constantly track and revise reporting on the political and economic unrest brought on by Russia's invasion of Ukraine. The world as a whole is expected to see negative effects, particularly in Eastern Europe, the European Union, Eastern and Central Asia, and the United States.

 North America will continue to hold a large portion of the cancer registration market, starting from its top counter.

 Elekta AB (PUB), IBM, Electronic Registry Systems, Inc., McKesson Corporation, Onco, Inc., MCKESSON CORPORATION, CONDUENT, INC, are the key players of Clinical Risk Grouping Solutions market

Table of Contents


1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions


2. Research Methodology


3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges


4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World


5. Value Chain Analysis


6. Porter’s 5 forces model


7.  PEST Analysis


8. Cancer Registry Software Market Segmentation, By Type

8.2 Standalone Software

8.2 Integrated Software


9. Cancer Registry Software Market Segmentation, By Deployment Model

9.1 On-premise

9.2 Cloud-based


10. Cancer Registry Software Market Segmentation, By Database

10.1 Commercial Databases

10.2 Public Databases


11. Cancer Registry Software Market Segmentation, By Functionality

11.1 Cancer Reporting to Meet State & Federal Regulations

11.2 Medical Research and Clinical Studies

11.3 Patient Care Management

11.4 Product Outcome Evaluation


12. Cancer Registry Software Market Segmentation, By End-User

12.1 Government Organizations & Third-party Administrators (TPAS)

12.2 Pharmaceutical, Biotechnology, & Medical Device Companies

12.3 Hospitals & Medical Practices

12.4 Private Payers

12.5 Research Centers


13. Regional Analysis

13.1 Introduction

13.2 North America

13.2.1 USA

13.2.2 Canada

13.2.3 Mexico

13.3 Europe

13.3.1 Germany

13.3.2 UK

13.3.3 France

13.3.4 Italy

13.3.5 Spain

13.3.6 The Netherlands

13.3.7 Rest of Europe

13.4 Asia-Pacific

13.4.1 Japan

13.4.2 South Korea

13.4.3 China

13.4.4 India

13.4.5 Australia

13.4.6 Rest of Asia-Pacific

13.5 The Middle East & Africa

13.5.1 Israel

13.5.2 UAE

13.5.3 South Africa

13.5.4 Rest

13.6 Latin America

13.6.1 Brazil

13.6.2 Argentina

13.6.3 Rest of Latin America


14. Company Profiles

14.1 Elekta AB (PUB),

14.1.1 Financial

14.1.2 Products/ Services Offered

14.1.3 SWOT Analysis

14.1.4 The SNS view

14.2 IBM

14.3 Electronic Registry Systems, Inc.

14.4 McKesson Corporation

14.5 Onco, Inc.




14.9 Rocky Mountain Cancer Data Systems

14.10 C/Net Solutions.


15. Competitive Landscape

15.1 Competitive Benchmark

15.2 Market Share Analysis

15.3 Recent Developments


16. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Share Page
Start a Conversation

Hi! Click one of our member below to chat on Phone